Palisade Bio shareholders approve reverse stock split of 1:5 to 1:50, board to decide ratio

PALISADE BIO, INC.

Three directors re-elected: J.D. Finley (647,086 votes for), Donald Williams (641,789), Emil Chuang (659,895); each had 2,849,169 broker non-votes.
Baker Tilly ratified as auditor for FY2025 with 3,348,348 votes for, 108,424 against.
Reverse stock split amendment approved 2,353,265 for to 1,122,616 against; board may set ratio 1:5 to 1:50, implement by Dec 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.